GF Fund Management’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
GF Fund Management's KYTX Position: Q3 2026 in Review
GF Fund Management increased its Kyverna Therapeutics (KYTX) stake by 8.8% in Q3 2026, buying an estimated $844 and bringing the position to 1,319 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #549.
GF Fund Management first reported a position in KYTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.8K in Q2 2026. 127 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- GF Fund Management held 1,319 shares of Kyverna Therapeutics worth $8.97K as of Q3 2026.
- GF Fund Management bought 107 Kyverna Therapeutics shares in Q3 2026, an estimated $844.
- Kyverna Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #549 holding.
- GF Fund Management first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 8 quarters since.
- GF Fund Management's Kyverna Therapeutics position peaked at $10.8K in Q2 2026.
- 127 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.